Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE CENTRALE IVRY RER : revenue, balance sheet and financial ratios

GRANDE PHARMACIE CENTRALE IVRY RER is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in IVRY-SUR-SEINE (94200), this company of category PME shows in 2024 a net income positive of 59 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE CENTRALE IVRY RER (SIREN 790786198)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 59 055 € 54 555 € 174 474 € 163 130 € 117 951 € 143 092 € 122 896 € 110 003 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, GRANDE PHARMACIE CENTRALE IVRY RER generates positive net income of 59 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 110 k€ -> 59 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

59 055 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 92%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.008%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

91.752%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

6.4%

Solvency indicators evolution
GRANDE PHARMACIE CENTRALE IVRY RER

Sector positioning

Debt ratio
0.01 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of GRANDE PHARMACIE CENTRALE... (0.01) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
91.75% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +14 pts over 3 years

In 2024, the financial autonomy of GRANDE PHARMACIE CENTRALE... (91.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 598.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

598.932

Liquidity indicators evolution
GRANDE PHARMACIE CENTRALE IVRY RER

Sector positioning

Liquidity ratio
598.93 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of GRANDE PHARMACIE CENTRALE... (598.93) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of GRANDE PHARMACIE CENTRALE IVRY RER in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of GRANDE PHARMACIE CENTRALE IVRY RER is estimated at 824 451 € (range 574 134€ - 1 233 426€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
574k€ 824k€ 1233k€
824 451 € Range: 574 134€ - 1 233 426€
NAF 5 année 2024

Valuation method used

Net Income Multiple
59 055 € × 14.0x = 824 451 €
Range: 574 135€ - 1 233 427€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE CENTRALE IVRY RER with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE CENTRALE IVRY RER

What is the revenue of GRANDE PHARMACIE CENTRALE IVRY RER ?

The revenue of GRANDE PHARMACIE CENTRALE IVRY RER is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE CENTRALE IVRY RER profitable?

Yes, GRANDE PHARMACIE CENTRALE IVRY RER generated a net profit of 59 k€ in 2024.

Where is the headquarters of GRANDE PHARMACIE CENTRALE IVRY RER ?

The headquarters of GRANDE PHARMACIE CENTRALE IVRY RER is located in IVRY-SUR-SEINE (94200), in the department Val-de-Marne.

Where to find the tax return of GRANDE PHARMACIE CENTRALE IVRY RER ?

The tax return of GRANDE PHARMACIE CENTRALE IVRY RER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE CENTRALE IVRY RER operate?

GRANDE PHARMACIE CENTRALE IVRY RER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.